Evaluating Prognosis in AL Amyloidosis: Can LV Strain Play a Role?

por Falk, Rodney H., Singh, Vasvi, Dorbala, Sharmila
Publicado 2020

Rhabdomyolysis in the Setting of Concomitant Use of Tafamidis, Atorvastatin, and Amiodarone

por Laird, Jessica, Falk, Rodney H., Coyle, Melissa, Cuddy, Sarah A.M.
Publicado 2020

Effect of Tafamidis on Serum Transthyretin Levels in Non-Trial Patients With Transthyretin Amyloid Cardiomyopathy

por Falk, Rodney H., Haddad, Mia, Walker, Crystal R., Dorbala, Sharmila, Cuddy, Sarah A.M.
Publicado 2021

Effect of tafamidis on global longitudinal strain and myocardial work in transthyretin cardiac amyloidosis

por Giblin, Gerard T, Cuddy, Sarah A M, González-López, Esther, Sewell, Alanna, Murphy, Amanda, Dorbala, Sharmila, Falk, Rodney H
Publicado 2022

Phase 2, open-label extension (OLE) study of revusiran, an investigational RNAi therapeutic for the treatment of patients with transthyretin cardiac amyloidosis

por Gillmore, Julian D, Falk, Rodney H, Maurer, Mathew S, Hanna, Mazen, Karsten, Verena, Vest, John, Gollob, Jared, Hawkins, Philip N
Publicado 2015

Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity

por Guan, Jian, Mishra, Shikha, Qiu, Yiling, Shi, Jianru, Trudeau, Kyle, Las, Guy, Liesa, Marc, Shirihai, Orian S, Connors, Lawreen H, Seldin, David C, Falk, Rodney H, MacRae, Calum A, Liao, Ronglih
Publicado 2014

Lysosomal dysfunction and impaired autophagy underlie the pathogenesis of amyloidogenic light chain-mediated cardiotoxicity

por Guan, Jian, Mishra, Shikha, Qiu, Yiling, Shi, Jianru, Trudeau, Kyle, Las, Guy, Liesa, Marc, Shirihai, Orian S, Connors, Lawreen H, Seldin, David C, Falk, Rodney H, MacRae, Calum A, Liao, Ronglih
Publicado 2015

Phase 3 Multicenter Study of Revusiran in Patients with Hereditary Transthyretin-Mediated (hATTR) Amyloidosis with Cardiomyopathy (ENDEAVOUR)

por Judge, Daniel P., Kristen, Arnt V., Grogan, Martha, Maurer, Mathew S., Falk, Rodney H., Hanna, Mazen, Gillmore, Julian, Garg, Pushkal, Vaishnaw, Akshay K., Harrop, Jamie, Powell, Christine, Karsten, Verena, Zhang, Xiaoping, Sweetser, Marianne T., Vest, John, Hawkins, Philip N.
Publicado 2020

Pharmacodynamic evaluation and safety assessment of treatment with antibodies to serum amyloid P component in patients with cardiac amyloidosis: an open-label Phase 2 study and an...

por Wechalekar, Ashutosh, Antoni, Gunnar, Al Azzam, Wasfi, Bergström, Mats, Biswas, Swethajit, Chen, Chao, Cheriyan, Joseph, Cleveland, Matthew, Cookson, Louise, Galette, Paul, Janiczek, Robert L., Kwong, Raymond Y., Lukas, Mary Ann, Millns, Helen, Richards, Duncan, Schneider, Ian, Solomon, Scott D., Sörensen, Jens, Storey, James, Thompson, Douglas, van Dongen, Guus, Vugts, Danielle J., Wall, Anders, Wikström, Gerhard, Falk, Rodney H.
Publicado 2022